110 related articles for article (PubMed ID: 16458450)
1. The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
Marangoni K; Neves AF; Cardoso AM; Santos WK; Faria PC; Goulart LR
Cancer Detect Prev; 2006; 30(1):7-13. PubMed ID: 16458450
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
Alonso V; Neves AF; Marangoni K; Faria PC; Freschi AP; Capaneli AC; Meola J; Goulart LR
Cancer Detect Prev; 2009; 32(4):336-7. PubMed ID: 19026495
[TBL] [Abstract][Full Text] [Related]
3. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
[TBL] [Abstract][Full Text] [Related]
4. The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression.
Marangoni K; Araújo TG; Neves AF; Goulart LR
BMC Cancer; 2008 Sep; 8():273. PubMed ID: 18823560
[TBL] [Abstract][Full Text] [Related]
5. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
6. Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7.
Medeiros RM; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Ferreira P; Lopes C
Clin Cancer Res; 2002 Nov; 8(11):3433-7. PubMed ID: 12429631
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer].
Weng ZL; Yu KY; Mao XL; Tao ZH; Chen XD; Wu XL; Hu YP; Wang SQ; Li CD; Chen ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2911-5. PubMed ID: 17288789
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
Faria PC; Saba K; Neves AF; Cordeiro ER; Marangoni K; Freitas DG; Goulart LR
Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
[TBL] [Abstract][Full Text] [Related]
9. DD3(PCA3) gene expression in cancer and prostatic hyperplasia.
Floriano-Sánchez E; Cárdenas-Rodríguez N; Castro-Marín M; Alvarez-Grave P; Lara-Padilla E
Clin Invest Med; 2009 Dec; 32(6):E258. PubMed ID: 20003831
[TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer.
Ziaei SA; Samzadeh M; Jamaldini SH; Afshari M; Haghdoost AA; Hasanzad M
Int J Biol Markers; 2013 Apr; 28(1):43-8. PubMed ID: 23015399
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients.
Medeiros R; Morais A; Vasconcelos A; Costa S; Carrilho S; Oliveira J; Lopes C
Cancer Lett; 2003 Jan; 189(1):85-90. PubMed ID: 12445681
[TBL] [Abstract][Full Text] [Related]
12. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease.
Elshamaa MF; Sabry S; Badr A; El-Ahmady M; Elghoroury EA; Thabet EH; Kandil D; Kamel S
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):487-92. PubMed ID: 21519233
[TBL] [Abstract][Full Text] [Related]
15. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
[TBL] [Abstract][Full Text] [Related]
16. Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis.
Sanli O; Kucukgergin C; Gokpinar M; Tefik T; Nane I; Seckin S
Urol Oncol; 2011; 29(2):183-8. PubMed ID: 19576798
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
Eur J Cancer Prev; 2002 Aug; 11(4):343-50. PubMed ID: 12195160
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
Fawzy MS; Mohamed RH; Elfayoumi AR
Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
